TrialAmerican heart journal2017

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

REVEAL Collaborative Group et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.